Skip to Content
Merck

943630

Mc-Val-Cit-PAB-Cl

≥95%

Synonym(s):

N-((S)-1-(((S)-1-((4-(Chloromethyl)phenyl)amino]-1-oxo-5-ureidopentan-2-yl)amino]-3-methyl-1-oxobutan-2-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide, N-[(1S)-1-[[(1S)-4-(carbamoylamino)-1-[[4-(chloromethyl)phenyl]-carbamoyl]butyl]carbamoyl]-2-methylpropyl]-6-(2,5-dioxopyrrol-1- yl)hexanamide, N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(chloromethyl)phenyl]-L-ornithinamide, L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(chloromethyl)phenyl], Mc-Val-Cit-PAB-Cl, Cleavable ADC Linker with Val-Cit / PAB Spacer

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C28H39ClN6O6
CAS Number:
Molecular Weight:
591.10
MDL number:
NACRES:
NA.21
Assay:
≥95%
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Segment

assay

≥95%

form

solid

storage condition

protect from light

color

off-white to pale yellow

storage temp.

−20°C

SMILES string

O=C(N)NCCCC(NC(=O)C(NC(=O)CCCCCN1C(=O)C=CC1=O)C(C)C)C(=O)NC2=CC=C(C=C2)CCl

InChI

1S/C28H39ClN6O6/c1-18(2)25(34-22(36)8-4-3-5-16-35-23(37)13-14-24(35)38)27(40)33-21(7-6-15-31-28(30)41)26(39)32-20-11-9-19(17-29)10-12-20/h9-14,18,21,25H,3-8,15-17H2,1-2H3,(H,32,39)(H,33,40)(H,34,36)(H3,30,31,41)/t21-,25-/m0/s1

InChI key

TUMQZNBKSWFFAZ-OFVILXPXSA-N

General description

Mc-Val-Cit-PAB-Cl is a protease-cleavable linker used in antibody-drug conjugates (ADCs). Specifically, it contains the Val-Cit (valine-citrulline) dipeptide motif, which is cleaved by cathepsin proteases in the lysosome, coupled with a PAB (para-aminobenzyl) carbamate (PAB-Cl indicates PAB with a chloromethyl group) self-immolative spacer, and a terminal chloromethyl phenyl group for conjugation. It’s designed to link the cytotoxic payload (e.g. MMAE) to an antibody, forming an ADC such as MC-VC-PABC-MMAE.

Application

  • Antibody-Drug Conjugates (ADCs): A linker component for ADCs, particularly with MMAE (Monomethyl auristatin E), forming ADCs with cytotoxic activity.
  • Cancer research: Used in preclinical ADC constructs against tumor cell lines. For example, anti-CD22-MC-VC-PABC-MMAE showing IC₅₀s in BJAB, WSU cell lines.
  • Bioconjugation chemistry: Useful as a linker for conjugating antibodies with small molecule payloads.

Features and Benefits

  • Cleavable by proteases (Val-Cit motif): Ensures drug release specifically in the target cell lysosome environment.
  • Self-immolative spacer (PAB-Cl): After proteolytic cleavage, the PAB spacer facilitates release of free drug.
  • Chloromethyl phenyl group: Provides a handle for stable conjugation chemistry to antibodies.

Other Notes

  • Protease cleavage: Val-Cit portion is recognized and cleaved by cathepsin enzymes (often cathepsin B) in lysosomes. Amide bond formation: The linker has amide bonds; payloads or antibodies typically conjugate via amine or thiol reactive groups.
  • Self-immolative release: After proteolytic trigger, the PAB spacer undergoes spontaneous decomposition to release the drug moiety.
  • Sensitivity: Must avoid conditions that degrade the Val-Cit or PAB moieties prematurely (e.g., perhaps strong acids, high temperatures, non-compatible buffers).


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Skin Sens. 1B

Storage Class

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library